NDT Advance Access published online on September 2, 2005
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfi082
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
* To whom correspondence should be addressed. Background. Although hyponatraemia [plasma sodium (PNa) <136 mmol/l] frequently develops in hospital, risk factors for hospital-acquired hyponatraemia remain unclear. Methods. Patients who presented with severe hyponatraemia (PNa Results. Thirty-eight patients had severe hyponatraemia on admission (PNa 121±4 mmol/l), whereas 36 patients had hospital-acquired severe hyponatraemia (PNa 133±5 Conclusions. The development of severe hyponatraemia in hospitalized patients was associated with treatment-related factors and inadequate management. Early recognition of risk factors and expedited therapy may make hospital-acquired severe hyponatraemia more preventable.
Received June 5, 2005
Accepted July 25, 2005
Original Articles
Development of severe hyponatraemia in hospitalized patients: treatment-related risk factors and inadequate management
2 Department of Clinical Chemistry, Erasmus Medical Center, Rotterdam, The Netherlands
Robert Zietse, E-mail: r.zietse{at}erasmusmc.nl
Abstract 
125 mmol/l) were compared with patients with hospital-acquired severe hyponatraemia in a 3 month hospital-wide cohort study.
122±4 mmol/l). In hospital-acquired hyponatraemia, treatment started significantly later (1.0±2.6 vs 9.8±10.6 days, P<0.001) and the duration of hospitalization was longer (18.2±11.5 vs 30.7±23.4 days, P = 0.01). The correction of PNa in hospital-acquired hyponatraemia was slower after both 24 h (6±4 vs 4±4 mmol/l, P = 0.009) and 48 h (10±6 mmol/l vs 6±5 mmol/l, P = 0.001) of treatment. Nineteen patients (26%) from both groups were not treated for hyponatraemia and this was associated with a higher mortality rate (seven out of 19 vs seven out of 55, P = 0.04). Factors that contributed to hospital-acquired hyponatraemia included: thiazide diuretics (none out of 38 vs eight out of 36, P = 0.002), drugs stimulating antidiuretic hormone (two out of 38 vs eight out of 36, P = 0.04), surgery (none out of 38 vs 10 out of 36, P<0.001) and hypotonic intravenous fluids (one out of 38 vs eight out of 36, P = 0.01). Symptomatic hyponatraemia was present in 27 patients (36%), and 14 patients died (19%).
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. O'Donoghue and A. Trehan SIADH and hyponatraemia: foreword NDT Plus, November 1, 2009; 2(suppl_3): iii1 - iii4. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Hoorn, N. van der Lubbe, and R. Zietse SIADH and hyponatraemia: why does it matter? NDT Plus, November 1, 2009; 2(suppl_3): iii5 - iii11. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Ayus, S. G. Achinger, and A. Arieff Brain cell volume regulation in hyponatremia: role of sex, age, vasopressin, and hypoxia Am J Physiol Renal Physiol, September 1, 2008; 295(3): F619 - F624. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Crop, E. J. Hoorn, J. Lindemans, and R. Zietse Hypokalaemia and subsequent hyperkalaemia in hospitalized patients Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3471 - 3477. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. Schrier Body Water Homeostasis: Clinical Disorders of Urinary Dilution and Concentration J. Am. Soc. Nephrol., July 1, 2006; 17(7): 1820 - 1832. [Full Text] [PDF]
|
|